Knowledge gaps about Tamiflu and Relenza for pandemic flu are blamed on research failure

BMJ. 2015 Oct 8:351:h5390. doi: 10.1136/bmj.h5390.
No abstract available

Publication types

  • News

MeSH terms

  • Antiviral Agents / therapeutic use
  • Biomedical Research*
  • Humans
  • Influenza A Virus, H1N1 Subtype*
  • Influenza, Human / drug therapy
  • Influenza, Human / epidemiology*
  • Oseltamivir / therapeutic use*
  • Pandemics / prevention & control*
  • Pandemics / statistics & numerical data
  • Zanamivir / therapeutic use*

Substances

  • Antiviral Agents
  • Oseltamivir
  • Zanamivir